UK markets closed

  • NIKKEI 225

    29,100.38
    -584.99 (-1.97%)
     

  • HANG SENG

    29,135.73
    +29.58 (+0.10%)
     

  • CRUDE OIL

    62.61
    +0.17 (+0.27%)
     

  • GOLD FUTURES

    1,778.80
    +0.40 (+0.02%)
     

  • DOW

    33,821.30
    -256.33 (-0.75%)
     

  • BTC-GBP

    40,376.69
    -298.84 (-0.73%)
     

  • CMC Crypto 200

    1,296.41
    +62.00 (+5.02%)
     

  • ^IXIC

    13,786.27
    -128.50 (-0.92%)
     

  • ^FTAS

    3,920.05
    -76.60 (-1.92%)
     
Cryptocurrency:

What is dogeday 4/20?

The joke cryptocurrency token dogecoin rallied as fans celebrated online

2021 World Inflammatory Pain Pipeline Insight

Research and Markets
·3-min read

Dublin, March 10, 2021 (GLOBE NEWSWIRE) -- The "Inflammatory Pain - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering.

This "Inflammatory Pain - Pipeline Insight, 2021," report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in the Inflammatory Pain pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

The report provides comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Inflammatory Pain pipeline landscape is provided which includes the disease overview and Inflammatory Pain treatment guidelines. The assessment part of the report embraces, in depth Inflammatory Pain commercial assessment and clinical assessment of the pipeline products under development. In the report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals and product development activities comprising the technology, Inflammatory Pain collaborations, licensing, mergers and acquisition, funding, designations and other product related details.

Report Highlights

  • The companies and academics are working to assess challenges and seek opportunities that could influence Inflammatory Pain R&D. The therapies under development are focused on novel approaches to treat/improve Inflammatory Pain.

The report covers around 3+ products under different phases of clinical development like

  • Late stage products (Phase III)

  • Mid-stage products (Phase II)

  • Early-stage product (Phase I) along with the details of

  • Pre-clinical and Discovery stage candidates

  • Discontinued & Inactive candidates

  • Route of Administration

Inflammatory Pain Report Insights

  • Inflammatory Pain Pipeline Analysis

  • Therapeutic Assessment

  • Unmet Needs

  • Impact of Drugs

Inflammatory Pain Report Assessment

  • Pipeline Product Profiles

  • Therapeutic Assessment

  • Pipeline Assessment

  • Inactive drugs assessment

  • Unmet Needs

Current Treatment Scenario and Emerging Therapies:

  • How many companies are developing Inflammatory Pain drugs?

  • How many Inflammatory Pain drugs are developed by each company?

  • How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Inflammatory Pain?

  • What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, licensing activities related to the Inflammatory Pain therapeutics?

  • What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?

  • What are the clinical studies going on for Inflammatory Pain and their status?

  • What are the key designations that have been granted to the emerging drugs?

Key Topics Covered:

Introduction

Executive Summary

Inflammatory Pain: Overview

  • Causes

  • Mechanism of Action

  • Signs and Symptoms

  • Diagnosis

  • Disease Management

Pipeline Therapeutics

  • Comparative Analysis

Therapeutic Assessment

  • Assessment by Product Type

  • Assessment by Stage and Product Type

  • Assessment by Route of Administration

  • Assessment by Stage and Route of Administration

  • Assessment by Molecule Type

  • Assessment by Stage and Molecule Type

Inflammatory Pain - Analytical Perspective

In-depth Commercial Assessment

  • Inflammatory Pain companies' collaborations, Licensing, Acquisition - Deal Value Trends

Inflammatory Pain Collaboration Deals

  • Company-Company Collaborations (Licensing / Partnering) Analysis

  • Company-University Collaborations (Licensing / Partnering) Analysis

Mid Stage Products (Phase II)

  • Comparative Analysis

CNTX 6970: Centrexion Therapeutics

  • Product Description

  • Research and Development

  • Product Development Activities

Early Stage Products (Phase I)

  • Comparative Analysis

AAV-AQP1: Kadmon Gene Therapy

  • Product Description

  • Research and Development

  • Product Development Activities

Inactive Products

  • Comparative Analysis

Inflammatory Pain Key Companies

Inflammatory Pain Key Products

Inflammatory Pain - Unmet Needs

Inflammatory Pain - Market Drivers and Barriers

Inflammatory Pain - Future Perspectives and Conclusion

Inflammatory Pain Analyst Views

Inflammatory Pain Key Companies

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/gjbeq

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Latest stories

  • Oregon Pacific Bank Announces First Quarter Earnings Results

    Oregon Pacific Bancorp (ORPB) today reported financial results for the first quarter ended March 31, 2021.

  • England’s big six have backed down but Super League fight isn’t over

    England’s big six have backed down but Super League fight isn’t overThe energy of football’s outrage over the Super League has been heartening, but this is just a retreat, a ceasefire Chelsea fans protest against the Super League outside Stamford Bridge before their team’s meeting with Brighton. Photograph: Andrew Cowie/Colorsport/Rex/Shutterstock

  • English clubs pull out of Super League as competition appears to crumble

    The flurry of withdrawals on Tuesday night came barely 48 hours after the breakaway league was officially announced.

  • Asia Stocks to Track U.S. Peers Lower; Bonds Climb: Markets Wrap

    (Bloomberg) -- Asian stocks looked set to track a decline in U.S. equities as rising virus cases around the world led to renewed concern about their economic impact, overshadowing a batch of solid corporate results. Bonds rose.Futures pointed lower in Japan, Australia and Hong Kong. U.S. contracts dipped, with Nasdaq 100 futures underperforming. Earlier, the S&P 500 fell for a second day extending its slide from an all-time high, with investors showing caution ahead of the brunt of the earnings season. European shares slumped. Treasuries rallied with the 10-year yield dropping to its lowest level in more than five weeks. The dollar advanced and oil prices retreated.After rising to record highs, stocks find themselves under pressure from a renewed surge in Covid-19 case around the world, raising the prospect of new lockdowns and hampering the economic recovery. In Toronto, health authorities will order workplaces to close if they have more than five confirmed cases of Covid-19 as the city struggles to contain a surge in variant cases.“Earnings season is ramping up, and there’s this concern about how the multinationals will give their guidance in view of the fact that we haven’t drawn a line under Covid yet,” said Fiona Cincotta, senior financial markets analyst at City Index. “That is just starting to unnerve investors. Demand for riskier assets has come off.”Among earnings, International Business Machines Corp. climbed after reporting its largest revenue growth in 11 quarters, while United Airlines Holdings Inc. paced a selloff in travel stocks on a bigger-than-expected loss. Netflix Inc. plunged in postmarket trading as its first-quarter subscriber growth fell short of the average analyst estimate.Read: Stumble in Stocks Lacks Easy Explanation for Wall Street PunditsHere are some key events to watch this week:EIA crude oil inventory report on Wednesday.European Central Bank rate decision and President Christine Lagarde briefing on Thursday.U.S. releases new home sales data Friday.These are some of the main moves in markets:StocksS&P 500 futures fell 0.1% as of 7.40 a.m. in Tokyo. The S&P 500 decreased 0.7%. The Nasdaq 100 dipped 0.7%Nikkei 225 futures fell 1.9%Australia’s S&P/ASX 200 Index futures dropped 1.2%Hong Kong’s Hang Seng Index futures slid 1.3%CurrenciesThe yen traded at 108.11 per dollarThe offshore yuan was at 6.4982 per dollarThe Bloomberg Dollar Spot Index advanced 0.2%The euro was little changed at $1.2033BondsThe yield on 10-year Treasuries fell four basis points to 1.56%CommoditiesWest Texas Intermediate crude fell 0.3% to $62.46 a barrelGold was at $1,778.45 an ounceFor more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Fox News’ Derek Chauvin Verdict Coverage Reveals a Divisive Network That Is Divided

    Before the verdict in the killing of George Floyd came in, Jake Tapper of CNN suggested that a guilty finding would potentially unite the nation. After cop Derek Chauvin was indeed found guilty on all three charges he faced, Fox News suggested that there had been no division in the first place. “This didn’t divide […]

  • Glow Up review – Bake Off for makeup offers joyful fun

    Glow Up review – Bake Off for makeup offers joyful funFrom Dolli’s vision of Afrofuturism to Ryley’s transformation of her port wine stain into a thing of sequinned, seascapey beauty, it’s a pleasure to watch these young makeup artists Ryley – one of the makeup artists on Glow Up. Photograph: Guy Levy/BBC/Wall To Wall

  • UiPath raises $1.34 billion in IPO - source

    Automation technology startup UiPath on Tuesday sold shares in its initial public offering (IPO) above its target range to raise $1.34 billion, a person familiar with the matter said. The company on Monday had increased its indicated target range to $52 and $54 per share, up from $43 to $50. Of the shares sold, 9.4 million were by UiPath and about 14.5 million were from existing investors.

  • Football world celebrates as European Super League project stalls

    The Premier League’s ‘big six’ pulled out of the controversial breakaway competition.

  • NBA, WNBA players react to guilty verdict in Derek Chauvin trial

    Several NBA and WNBA players demanded the need for further accountability after former police officer Derek Chauvin was found guilty of murdering George Floyd.

  • James Harden suffers 'setback,' now out indefinitely with hamstring injury

    "Were back to square one."

  • George Floyd killing: President Biden shares his 'relief' with Floyd family after Derek Chauvin convicted of murder

    US President Joe Biden has told the family of George Floyd he is "relieved" after former police officer Derek Chauvin was convicted of his murder. Chauvin, 45, had denied all three counts, but was found unanimously guilty of second-degree murder, third-degree murder and second-degree manslaughter. Mr Biden called the Floyd family immediately after the verdict.

  • English clubs to quit European Super League following fan backlash

    Boris Johnson had previously warned he was prepared to legislate to block the new league plans.

  • ‘The world is watching’: The fight for Minneapolis police reform after Derek Chauvin’s murder conviction

    Derek Chauvin may have been found guilty of murder, but the people of Minneapolis say true justice is much bigger than one court decision

  • Former police officer Derek Chauvin found guilty of murdering George Floyd

    Derek Chauvin has been convicted of murder for killing George Floyd by kneeling on his neck for more than nine minutes. The former Minneapolis police officer’s crime prompted a wave of protests in support of racial justice in the US and across the world. The jury unanimously convicted Chauvin of all the charges he faced - second and third degree murder, and manslaughter.

  • Nancy Pelosi: 'Thank You, George Floyd, For Sacrificing Your Life'

    The speaker of the House of Representatives made the widely criticized comment soon after a jury convicted former police officer Derek Chauvin of murdering Floyd.

  • Biden to Vow Cutting U.S. Climate-Warming Emissions in Half

    (Bloomberg) -- White House officials have told supporters they will pledge to reduce U.S. greenhouse gas emissions by at least half by the end of the decade, according to people familiar with the plans, an almost doubling of the nation’s earlier commitment.The administration has notified supporters this week that President Joe Biden will declare a goal of halving the nation’s emissions from 2005 levels as he pushes to transform vast sectors of the economy and become a leader in the global fight against climate change, according to two people briefed by administration officials who asked not to be identified discussing private matters.A reduction of 50% by 2030 would represent a near doubling of a climate target for 2025 set by the Obama administration. One of the people said the administration was seeking to avoid laying down a numeric target.The U.S. may also commit to working to achieve even deeper cuts, one of the people said. That mirrors an approach the Obama administration took in 2015, when it laid out a 26%-28% cut by 2025, but said it would work to achieve the higher, 28% reduction.The White House declined to comment.Achieving the reduction on the scale being planned will require sweeping changes for power generation, transportation and manufacturing. The U.S. pledge is part of a global push to keep average global temperature from rising more than 1.5 degrees Celsius (2.7 degrees Fahrenheit).Biden will outline the target as part of the U.S. return to the Paris climate accord and as he prepares for a summit Thursday and Friday with the leaders of up to 40 nations designed to encourage greater carbon-cutting ambition.The summit’s objective is to encourage major economies to boost their carbon-cutting commitments so that the 1.5°C goal is within reach. While it may not deliver immediate wins on that front, the gathering could help to galvanize momentum ahead of the United Nations negotiations due to be held in November in Glasgow, Scotland.The planned U.S. pledge won plaudits from some environmentalists who said deep cuts were necessary given the country’s longstanding role as a top source of carbon dioxide emissions globally.“We cannot preach temperance from a barstool and not pay our fair share when approximately 40% of all the excess carbon dioxide in the atmosphere is red, white, and blue,” said Senator Ed Markey, a Democrat from Massachusetts. “A 50% reduction by 2030 is technically feasible and well within our reach.”Markey said he was still pressing the administration to commit to more climate aid for helping developing nations and to lay out an explicit pledge to pare emissions of the particularly potent greenhouse gas methane.Wyoming Senator John Barrasso called the pledge “drastic and damaging.”“The last thing the economy needs is higher energy prices and fewer jobs, but that’s exactly what we’re going to get,” said Barrasso, the ranking Republican on the Senate Energy and Natural Resources Committee. “The president’s scheme will cost working families a fortune in higher energy bills. It will also hurt America’s international competitiveness.”A 50% emissions reduction would require far-reaching changes across the U.S. economy, going well beyond the power sector, ClearView Energy Partners said in a note for clients.“At risk of mild exaggeration, if other sectors’ business-as-usual trends persist, then even with steep power-sector cuts, light-duty transportation might need to substantially shift to bicycles to hit” a 50% reduction target, the research group said.The administration’s target could face criticism from other countries that have set more ambitious targets and are skeptical of the U.S. commitment to battling climate change after President Donald Trump withdrew from the Paris accord and relaxed curbs on emissions.Biden’s pledge is less ambitious than the European Union’s target of reducing its emissions 55% from 1990 levels by 2030. And it falls below a coming U.K goal to achieve a 78% reduction by 2035 from 1990 levels. A 50% cut from 2005 emissions would amount to just a 40% cut for the U.S. when recalibrated to the same 1990 baseline.(Updates with details and reaction from senator from ninth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Nationals put Juan Soto on IL with strained left shoulder

    Washington Nationals right fielder Juan Soto went on the 10-day injured list with a strained left shoulder on Tuesday, the latest setback for the 2019 World Series champions. The club also said that outfielder Yadiel Hernandez was being recalled from its alternate training site.

  • The vital importance of talking about the Chauvin verdict at work

    The news that a jury found former Minneapolis police officer Derek Chauvin guilty of murdering George Floyd is already sparking a wide range of reactions, from celebration and relief that Chauvin is being held accountable, to grief, anxiety, and anger over Floyd’s death and continued police violence against Black people. In the coming days, it will be crucial for managers and employers to support their Black employees by acknowledging that. “A lot of times we aren’t sure what to say, so we just back away and don’t say anything,” says social psychologist Evelyn Carter, the director of training and people development at the diversity and inclusion firm Paradigm Strategy.

  • Chile legislature OKs euthanasia bill, which heads to Senate

    Chile’s Chamber of Deputies on Tuesday approved a bill to allow euthanasia and assisted suicide for those over 18. It now goes to the Senate for debate. Under the legislation, which was submitted to congress by the center-left opposition in 2014, a person seeking euthanasia would have to be diagnosed by two doctors as having a serious and incurable disease, be conscious when making the request or have previously established the request, and suffer from unbearable physical ailments.

  • ‘We cannot rest’: Obama calls for ‘concrete reforms’ after Derek Chauvin verdict

    Former president echoes demands for ‘true justice’ in wake of guilty verdicts